Friday 8 April 2022

Clinical Trajectories in Early Seropositive Rheumatoid Arthritis

Not all patients respond equally well to treatment.  Here is the link to the clinical trajectories paper identifying three distinct trajectories for early seropositive rheumatoid arthritis patients.

RA-MAP Consortium, 2021. Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study. Therapeutic advances in musculoskeletal disease13, p.1759720X211043977.

No comments:

Post a Comment

Note: only a member of this blog may post a comment.